2m 2m 2m 2m 2m 2m 2m
REDHILL BIO SP ADS (RDHL)
NASDAQ
$0.97-$0.04 (-3.76%)
Price as of Jun 03, 2026 6:56 PM EDT- $5.2MMarket Cap
- -45.70%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
REDHILL BIO SP ADS (RDHL)
$0.97-$0.04 (-3.76%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 286,000 -96.44% | 8.0M +23.17% | 6.5M -89.43% | 61.8M -27.94% | |
Cost of Revenue | 2.0M -38.06% | 3.2M -7.72% | 3.5M -89.62% | 33.3M -32.52% | |
Gross Profit | 5.5M +13.65% | 4.9M +57.96% | 3.1M -89.21% | 28.5M -21.70% | |
Sales and Marketing Expense | 6.2M -35.49% | 9.6M -41.01% | 16.2M -43.26% | 28.6M -11.68% | |
Research and Development Expense | -2.0M +27.39% | -1.6M -54.99% | -3.5M -51.53% | -7.3M -75.32% | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 6.2M -35.49% | 9.6M -41.01% | 16.2M -43.26% | 28.6M -11.68% | |
Operating Profit | -7.9M -45.65% | -14.6M -215.68% | 12.6M +129.48% | -42.8M -47.19% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -367,000 -99.06% | -39.1M +227.63% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -367,000 -99.06% | -39.1M +227.63% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | 367,000 -99.06% | 39.1M +227.63% | |
Income before Taxes | -429,000 -94.81% | -8.3M -134.57% | 23.9M +133.37% | -71.7M -26.68% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -429,000 -94.81% | -8.3M -134.57% | 23.9M +133.37% | -71.7M -26.68% | |
Net Income from Continuing Operations Applicable to Common | -429,000 -94.81% | -8.3M -134.57% | 23.9M +133.37% | -71.7M -26.68% | |
Basic EPS and Net Income | 0.00 N/A | 0.00 -100.00% | 0.01 +108.33% | -0.12 -42.86% | |
Diluted EPS and Net Income | 0.00 N/A | 0.00 -100.00% | 0.01 +108.33% | -0.12 -42.86% | |
Basic Weighted Average Shares | 31.6B +156.37% | 12.3B +375.56% | 2.6B +318.41% | 619.3M +33.10% | |
Diluted Weighted Average Shares | 31.6B +156.37% | 12.3B +375.56% | 2.6B +318.41% | 619.3M +33.10% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.0M -13.99% | 4.6M -17.09% | 5.6M -72.11% | 20.0M -32.25% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 4.0M -13.99% | 4.6M -17.09% | 5.6M -72.11% | 20.0M -32.25% | |
Total Current Assets | 6.5M -45.19% | 11.9M -26.20% | 16.1M -81.21% | 85.9M -3.65% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 49,000 -63.70% | 135,000 -30.05% | 193,000 -61.55% | 502,000 -12.24% | |
Total Long-Term Assets | 18.8M +206.87% | 6.1M -11.22% | 6.9M -90.53% | 73.0M -20.72% | |
Total Assets | 25.3M +40.47% | 18.0M -21.71% | 23.0M -85.49% | 158.9M -12.32% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 115.2M 0.00% | 115.2M N/A | |
Total Current Liabilities | 19.2M -13.51% | 22.2M +15.49% | 19.2M -90.25% | 197.5M +142.36% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.9M +268.99% | 503,000 -71.03% | 1.7M -82.31% | 9.8M -89.19% | |
Total Liabilities | 21.1M -7.26% | 22.7M +8.33% | 21.0M -89.88% | 207.3M +20.29% | |
Retained Earnings | -413.8M -0.25% | -414.8M +1.73% | -407.7M -6.02% | -433.9M +17.94% | |
Total Stockholders Equity | 4.3M +101.03% | -414.8M -20,148.38% | 2.1M +104.27% | -48.4M -645.35% | |
Total Shares Outstanding | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash Flow | |||||
Cash from Operating Activities | -9.7M +3.01% | -9.4M -73.84% | -35.8M +22.73% | -29.2M -55.13% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 1.7M +18,888.89% | -9,000 -325.00% | 4,000 -99.95% | 8.3M +201.99% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 7.3M -13.07% | 8.4M -60.74% | 21.4M +87.19% | 11.5M -84.41% | |
Financials Ratio | |||||
Gross Margin | -591.26% -1,080.31% | 60.31% +28.25% | 47.03% +2.11% | 46.06% +8.65% | |
Operating Margin | -2,776.92% +1,428.42% | -181.69% -193.92% | 193.45% +379.03% | -69.33% -26.72% | |
Return on Assets | -1.98% -95.09% | -40.24% -253.06% | 26.29% +162.38% | -42.15% -22.07% | |
Return on Equity | 0.21% -94.78% | 4.01% +103.88% | -103.24% -128.47% | 362.65% +142.18% | |
Revenue Growth | -96.44% -516.25% | 23.17% +125.91% | -89.43% +220.14% | -27.94% -184.02% | |
Current Ratio | 0.34 -36.64% | 0.54 -36.10% | 0.84 +92.83% | 0.44 -60.25% | |
Cash Ratio | 0.21 -0.58% | 0.21 -28.20% | 0.29 +186.25% | 0.10 -72.06% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow